Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

BeOne Medicines (BEIGF) Debt Ratio (2016 - 2025)

BeOne Medicines (BEIGF) has disclosed Debt Ratio for 11 consecutive years, with 0.12 as the latest value for Q4 2025.

  • Quarterly Debt Ratio fell 27.61% to 0.12 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.12 through Dec 2025, down 27.61% year-over-year, with the annual reading at 0.12 for FY2025, 27.61% down from the prior year.
  • Debt Ratio for Q4 2025 was 0.12 at BeOne Medicines, down from 0.22 in the prior quarter.
  • The five-year high for Debt Ratio was 0.22 in Q3 2025, with the low at 0.04 in Q4 2022.
  • Average Debt Ratio over 5 years is 0.13, with a median of 0.12 recorded in 2021.
  • The sharpest move saw Debt Ratio soared 305.01% in 2021, then tumbled 48.28% in 2022.
  • Over 5 years, Debt Ratio stood at 0.07 in 2021, then crashed by 48.28% to 0.04 in 2022, then soared by 299.97% to 0.15 in 2023, then grew by 12.66% to 0.17 in 2024, then fell by 27.61% to 0.12 in 2025.
  • According to Business Quant data, Debt Ratio over the past three periods came in at 0.12, 0.22, and 0.15 for Q4 2025, Q3 2025, and Q2 2025 respectively.